贛鋒鋰業(01772.HK)完成註銷2022年股票期權激勵計劃部分股票期權
格隆匯10月9日丨贛鋒鋰業(01772.HK)公吿,江西贛鋒鋰業集團股份有限公司(以下簡稱“公司”)於2024年6月26日召開的第五屆董事會第八十三次會議和第五屆監事會第五十七次會議,審議通過了《關於註銷部分股票期權的議案》,公司對3名離職人員其157,500份股票期權及2022年股票期權激勵計劃第一期剩餘105名(含上述離職人員)行權期到期未行權其675,500份股票期權,本次涉及註銷人數105名,共計833,000份股票期權予以註銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.